Suppr超能文献

高良姜提取物抗流感病毒感染和血凝作用的体外抑制活性。

In vitro inhibitory activity of Alpinia katsumadai extracts against influenza virus infection and hemagglutination.

机构信息

Eco-Friendly Biomaterial Research Center and AI Control Material Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup 580-185, Republic of Korea.

出版信息

Virol J. 2010 Nov 10;7:307. doi: 10.1186/1743-422X-7-307.

Abstract

BACKGROUND

Alpinia katsumadai (AK) extracts and fractions were tested for in vitro antiviral activities against influenza virus type A, specially human A/PR/8/34 (H1N1) and avian A/Chicken/Korea/MS96/96 (H9N2), by means of time-of-addition experiments; pre-treatment, simultaneous treatment, and post treatment.

RESULTS

In pre-treatment assay, the AK extracts and AK fractions did not show significant antiviral activity. During the simultaneous treatment assay, one AK extract and five AK fractions designated as AK-1 to AK-3, AK-5, AK-10, and AK-11 showed complete inhibition of virus infectivity against A/PR/8/34 (H1N1) and A/Chicken/Korea/MS96/96 (H9N2). The 50% effective inhibitory concentrations (EC₅₀) of these one AK extracts and five AK fractions with exception of the AK-9 were from 0.8 ± 1.4 to 16.4 ± 4.5 μg/mL against A/PR/8/34 (H1N1). The two AK extracts and three AK fractions had EC₅₀ values ranging from <0.39 ± 0.4 to 2.3 ± 3.6 μg/mL against A/Chicken/Korea/MS96/96 (H9N2). By the hemagglutination inhibition (HI) assay, the two AK extracts and five AK fractions completely inhibited viral adsorption onto chicken RBCs at less than 100 μg/mL against both A/PR/8/34 (H1N1) and A/Chicken/Korea/MS96/96 (H9N2). Interestingly, only AK-3 was found with inhibition for both viral attachment and viral replication after showing extended antiviral activity during the post treatment assay and quantitative real-time PCR.

CONCLUSIONS

These results suggest that AK extracts and fractions had strong anti-influenza virus activity that can inhibit viral attachment and/or viral replication, and may be used as viral prophylaxis.

摘要

背景

采用时效关系实验,对高良姜(AK)提取物及其馏分进行了抗甲型流感病毒(特别是人 A/PR/8/34(H1N1)和禽 A/鸡/韩国/MS96/96(H9N2))的体外抗病毒活性测试,进行了预处理、同时处理和后处理。

结果

在预处理试验中,AK 提取物和 AK 馏分没有显示出显著的抗病毒活性。在同时处理试验中,一种 AK 提取物和五种 AK 馏分,分别命名为 AK-1 至 AK-3、AK-5、AK-10 和 AK-11,对 A/PR/8/34(H1N1)和 A/鸡/韩国/MS96/96(H9N2)显示出完全抑制病毒感染力的作用。除 AK-9 外,这些 AK 提取物和 AK 馏分中的一种对 A/PR/8/34(H1N1)的 50%有效抑制浓度(EC₅₀)为 0.8 ± 1.4 至 16.4 ± 4.5μg/ml,对 A/鸡/韩国/MS96/96(H9N2)的 EC₅₀ 值为 0.39 ± 0.4 至 2.3 ± 3.6μg/ml。两种 AK 提取物和三种 AK 馏分对 A/鸡/韩国/MS96/96(H9N2)的 EC₅₀ 值均小于 0.39 ± 0.4μg/ml。通过血凝抑制(HI)试验,两种 AK 提取物和五种 AK 馏分在小于 100μg/ml 时完全抑制了病毒吸附到鸡 RBC 上,对 A/PR/8/34(H1N1)和 A/鸡/韩国/MS96/96(H9N2)均有抑制作用。有趣的是,只有 AK-3 在后续处理试验和实时定量 PCR 中显示出延长的抗病毒活性后,才发现对病毒附着和病毒复制均有抑制作用。

结论

这些结果表明,AK 提取物及其馏分具有较强的抗流感病毒活性,可抑制病毒附着和/或病毒复制,可作为病毒预防用药。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a4f/2989970/c929ba01dcb2/1743-422X-7-307-1.jpg

相似文献

2
Antiviral activity of hydroalcoholic extract from Eupatorium perfoliatum L. against the attachment of influenza A virus.
J Ethnopharmacol. 2016 Jul 21;188:144-52. doi: 10.1016/j.jep.2016.05.016. Epub 2016 May 10.
3
Antiviral activity of Alpinia katsumadai extracts against rotaviruses.
Res Vet Sci. 2012 Apr;92(2):320-3. doi: 10.1016/j.rvsc.2010.11.012. Epub 2010 Dec 31.
4
Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2.
J Ethnopharmacol. 2020 Sep 15;259:112945. doi: 10.1016/j.jep.2020.112945. Epub 2020 May 7.
8
Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities.
Bioorg Med Chem. 2009 Oct 1;17(19):6816-23. doi: 10.1016/j.bmc.2009.08.036. Epub 2009 Aug 21.
9
Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.
Antiviral Res. 2007 Nov;76(2):178-85. doi: 10.1016/j.antiviral.2007.07.001. Epub 2007 Aug 1.
10
In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives.
Antiviral Res. 2012 Jun;94(3):217-24. doi: 10.1016/j.antiviral.2012.04.001. Epub 2012 Apr 13.

引用本文的文献

3
Identifying citrus limonoids as a potential fusion inhibitor of DENV-2 virus through its in silico study and FTIR analysis.
In Silico Pharmacol. 2024 Apr 25;12(1):35. doi: 10.1007/s40203-024-00207-2. eCollection 2024.
5
Inactivation of plant and animal viruses by proanthocyanidins from extract.
Plant Biotechnol (Tokyo). 2021 Dec 25;38(4):453-455. doi: 10.5511/plantbiotechnology.21.0925a.
6
Biomedical Applications of Chinese Herb-Synthesized Silver Nanoparticles by Phytonanotechnology.
Nanomaterials (Basel). 2021 Oct 18;11(10):2757. doi: 10.3390/nano11102757.
7
Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic.
Front Med (Lausanne). 2020 Aug 7;7:444. doi: 10.3389/fmed.2020.00444. eCollection 2020.
9
Antiviral potential of green synthesized silver nanoparticles of and .
Int J Nanomedicine. 2019 Aug 6;14:6217-6229. doi: 10.2147/IJN.S214171. eCollection 2019.
10
Luteolin decreases the yield of influenza A virus in vitro by interfering with the coat protein I complex expression.
J Nat Med. 2019 Jun;73(3):487-496. doi: 10.1007/s11418-019-01287-7. Epub 2019 Feb 13.

本文引用的文献

1
Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients.
J Antimicrob Chemother. 2010 Apr;65 Suppl 2(Suppl 2):ii11-ii24. doi: 10.1093/jac/dkq012.
5
Historical perspective--Emergence of influenza A (H1N1) viruses.
N Engl J Med. 2009 Jul 16;361(3):279-85. doi: 10.1056/NEJMra0904322. Epub 2009 Jun 29.
6
Emergence of a novel swine-origin influenza A (H1N1) virus in humans.
N Engl J Med. 2009 Jun 18;360(25):2605-15. doi: 10.1056/NEJMoa0903810. Epub 2009 May 7.
7
Pandemic and seasonal influenza: therapeutic challenges.
Drug Discov Today. 2008 Jul;13(13-14):590-5. doi: 10.1016/j.drudis.2008.03.024. Epub 2008 May 15.
8
Antiviral management of seasonal and pandemic influenza.
J Infect Dis. 2006 Nov 1;194 Suppl 2:S119-26. doi: 10.1086/507552.
9
Anti-influenza virus agents: synthesis and mode of action.
Med Res Rev. 2008 Jan;28(1):1-38. doi: 10.1002/med.20096.
10
Antiviral agents active against influenza A viruses.
Nat Rev Drug Discov. 2006 Dec;5(12):1015-25. doi: 10.1038/nrd2175.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验